Taken together, to ascertain the potential immunotherapeutic targets in locally advanced rectal cancer, we explored the prognostic associations of MDSC infiltration in combination with the expression levels of the PD-1/PD-L1 axis in the tumor microenvironment. This evidence concerns the gene PDCD1 and rectal cancer.